A new stem cell treatment could eliminate the need for insulin therapy in people with type 1 diabetes, a disease where the ...

According to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type ...

New advancements in stem cell therapy offer hope for insulin independence and improved diabetes management. By Cameron French Jan 28, 2025 11:15 am Photo credit: Shutterstock.com / LightField Studios ...

Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear.In this multicenter, controlled trial, we randomly assigned ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...

He has calculated that the annual extra cost of glucagon in Norway will be around NOK 100 for a patient with an average consumption of 60 units of insulin per day. At the top of discouraging ...

Women successfully using insulin before conception often benefit from continuing this treatment, potentially adding metformin as a complementary therapy rather than replacing insulin entirely.